Massive potential1 Jun 2018 09:55
Collaboration Agreement & Strategic Investment in Eranova SAS, initially subscribe to 8% with option to increase to 51%
The above to provide new generation of bio-based polymers that are affordable and pay due respect to the environment
World First � Launch of New Latex Antimicrobial Examination Glove and Antimicrobial Healthcare Products, made with d2p technology. Biomax products are sold in more than 40 countries worldwide
�621,000 cash, revenue up approx. �8.2million, 2018 expected to be even stronger in growth
MoU to acquire Symphony�s existing European distributors. This would provide Symphony with �2.5 million of revenues primarily into the French major retail market.
11 Countries legislated in favour of oxo-biodegradable plastic technology such as d2w.
Symphony is actively engaged with the UK government and hopes oxo-biodegradable technologies will deal with the plastic issue.
d2w was the first oxo-biodegradable additive approved in Saudi Arabia and sales have exceeded the UAE volumes in less than 1 year.
Symphony is to capitalise on the groups profile during this pivotal period and has budgeted �375,000 higher than 2017 for communications and marketing.